ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

SNSE Sensei Biotherapeutics Inc

1.81
0.00 (0.00%)
Pre Mercado
Última actualización: 06:54:59
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Sensei Biotherapeutics Inc SNSE NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.00 0.00% 1.81 06:54:59
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.81
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
05/3/202415:44EDGAR2Form 8-K - Current report
28/2/202406:31EDGAR2Form 8-K - Current report
16/2/202417:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202417:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202417:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202415:31EDGAR2Form 8-K - Current report
04/1/202407:14EDGAR2Form 8-K - Current report
07/11/202315:40EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202306:35EDGAR2Form 8-K - Current report
07/11/202306:30GLOBESensei Biotherapeutics Reports Third Quarter 2023 Financial..
06/11/202305:07EDGAR2Form 8-K - Current report
03/11/202315:11EDGAR2Form 8-K - Current report
03/11/202315:05GLOBESensei Biotherapeutics Reports Favorable Clinical Data for..
02/11/202315:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/11/202315:50EDGAR2Form 3 - Initial statement of beneficial ownership of..
01/11/202306:30GLOBESensei Biotherapeutics Appoints Stephanie Krebs, MS, MBA, as..
25/10/202308:05GLOBESensei Biotherapeutics to Present Initial Clinical Data from..
23/10/202306:30GLOBESensei Biotherapeutics Presents Trial-in-Progress Poster for..
20/10/202316:01EDGAR2Form 8-K - Current report
27/9/202306:30GLOBESensei Biotherapeutics Announces Initiation of Combination..
21/9/202306:30GLOBESensei Biotherapeutics Presents New Preclinical Data..
13/9/202307:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202306:30GLOBESensei Biotherapeutics to Present New Preclinical Data..
11/9/202316:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/9/202316:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/9/202316:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/9/202316:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/8/202306:30GLOBESensei Biotherapeutics to Participate in Upcoming Investor..
17/8/202316:15EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
03/8/202315:32EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/8/202307:45EDGAR2Form 8-K - Current report
03/8/202306:30GLOBESensei Biotherapeutics Reports Second Quarter 2023 Financial..
02/8/202316:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/8/202306:30GLOBESensei Biotherapeutics to Participate in Canaccord Genuity’s..
12/7/202315:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/7/202315:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/7/202315:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/7/202315:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/7/202315:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/7/202315:31EDGAR2Form 8-K - Current report
01/6/202306:30GLOBESensei Biotherapeutics Announces First Patient Dosed in..
09/5/202306:30GLOBESensei Biotherapeutics Reports First Quarter 2023 Financial..

Su Consulta Reciente

Delayed Upgrade Clock